The innovative QG-MPH assay offers a multiplexed and accurate measurement of the HPV E7 and p16 mRNA in HNSCC specimen and enables more precise differentiation between truly HPV-driven HNSCC and transcriptionally silent, non-etiological HPV infections. This evidence concerns the gene CDKN2A and head and neck squamous cell carcinoma.